During the past decade, Georgia Cancer Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Cancer Specialists" #1 sponsor was "Merrimack Pharmaceuticals" with 1 trials, followed by "Millennium Pharmaceuticals, Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "University of Alabama at Birmingham" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Cancer Specialists" #1 collaborator was "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "National Comprehensive Cancer Network" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Cancer Specialists" are "B-Cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Chemonaive" (1 trials), "ER Positive, Her2 Negative Breast Cancer Patients" (1 trials) and "Extensive Stage Lung Cancer" (1 trials). Many other conditions were trialed in "Georgia Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Georgia Cancer Specialists" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Cancer Specialists" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Georgia Cancer Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Georgia Cancer Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Cancer Specialists, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".